Literature DB >> 16004619

Decreased frontal white-matter volume in chronic substance abuse.

Thomas E Schlaepfer1, Eric Lancaster, Rebecca Heidbreder, Eric C Strain, Markus Kosel, Hans-Ulrich Fisch, Godfrey D Pearlson.   

Abstract

There is quite a body of work assessing functional brain changes in chronic substance abuse, much less is known about structural brain abnormalities in this patient population. In this study we used magnetic resonance imaging (MRI) to determine if structural brain differences exist in patients abusing illicit drugs compared to healthy controls. Sixteen substance abusers who abused heroin, cocaine and cannabis but not alcohol and 16 age-, sex- and race-matched controls were imaged on a MRI scanner. Contiguous, 5-mm-thick axial slices were acquired with simultaneous T2 and proton density sequences. Volumes were estimated for total grey and white matter, frontal grey and white matter, ventricles, and CSF using two different methods: a conventional segmentation and a stereological method based on the Cavalieri principle. Overall brain volume differences were corrected for by expressing the volumes of interest as a percentage of total brain volume. Volume measures obtained with the two methods were highly correlated (r=0.65, p<0.001). Substance abusers had significantly less frontal white-matter volume percentage than controls. There were no significant differences in any of the other brain volumes measured. This difference in frontal lobe white matter might be explained by a direct neurotoxic effect of drug use on white matter, a pre-existing abnormality in the development of the frontal lobe or a combination of both effects. This last explanation might be compelling based on the fact that newer concepts on shared aspects of some neuropsychiatric disorders focus on the promotion and inhibition of the process of myelination throughout brain development and subsequent degeneration.

Entities:  

Mesh:

Year:  2005        PMID: 16004619     DOI: 10.1017/S1461145705005705

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  32 in total

Review 1.  Predicting the risk of psychosis onset: advances and prospects.

Authors:  Eric V Strobl; Shaun M Eack; Vaidy Swaminathan; Shyam Visweswaran
Journal:  Early Interv Psychiatry       Date:  2012-07-08       Impact factor: 2.732

2.  Morphometric brain abnormalities in schizophrenia in a population-based sample: relationship to duration of illness.

Authors:  Päivikki Tanskanen; Khanum Ridler; Graham K Murray; Marianne Haapea; Juha M Veijola; Erika Jääskeläinen; Jouko Miettunen; Peter B Jones; Edward T Bullmore; Matti K Isohanni
Journal:  Schizophr Bull       Date:  2008-11-17       Impact factor: 9.306

3.  Methadone use in a male with the FMRI premutation and FXTAS.

Authors:  Zukhrofi Muzar; Reymundo Lozano; Andrea Schneider; Patrick E Adams; Sultana M H Faradz; Flora Tassone; Randi J Hagerman
Journal:  Am J Med Genet A       Date:  2015-04-21       Impact factor: 2.802

Review 4.  Abuse of amphetamines and structural abnormalities in the brain.

Authors:  Steven Berman; Joseph O'Neill; Scott Fears; George Bartzokis; Edythe D London
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

5.  Amphetamine dependence and co-morbid alcohol abuse: associations to brain cortical thickness.

Authors:  Glenn Lawyer; Petr S Bjerkan; Anders Hammarberg; Nitya Jayaram-Lindström; Johan Franck; Ingrid Agartz
Journal:  BMC Pharmacol       Date:  2010-05-20

6.  Isolating cognitive and neurologic HIV effects in substance-dependent, confounded cohorts: a pilot study.

Authors:  Desiree A Byrd; Jessica Robinson-Papp; Monica Rivera Mindt; Letty Mintz; Kathryn Elliott; Quenesha Lighty; Susan Morgello
Journal:  J Int Neuropsychol Soc       Date:  2013-02-28       Impact factor: 2.892

7.  Insula and orbitofrontal cortical morphology in substance dependence is modulated by sex.

Authors:  J Tanabe; P York; T Krmpotich; D Miller; M Dalwani; J T Sakai; S K Mikulich-Gilbertson; L Thompson; E Claus; M Banich; D C Rojas
Journal:  AJNR Am J Neuroradiol       Date:  2012-11-15       Impact factor: 3.825

8.  Managing addiction as a chronic condition.

Authors:  Michael Dennis; Christy K Scott
Journal:  Addict Sci Clin Pract       Date:  2007-12

Review 9.  Imaging the addicted human brain.

Authors:  Joanna S Fowler; Nora D Volkow; Cheryl A Kassed; Linda Chang
Journal:  Sci Pract Perspect       Date:  2007-04

10.  The impacts of substance abuse and dependence on neuropsychological functions in a sample of patients from Saudi Arabia.

Authors:  Mohamed A Al-Zahrani; Yasser A Elsayed
Journal:  Behav Brain Funct       Date:  2009-12-11       Impact factor: 3.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.